NASDAQ · STEXHealthcareElectromedical Equipment

Streamex financials

$0.6731−4.50%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Revenue$146.0K$0.00$0.00$0.00
Gross profit$146.0K$0.00$0.00$0.00
Gross margin100.0%———
Operating income-$15.2M-$35.7M-$41.6M-$6.1M
Net income-$14.6M-$46.7M-$424.0M-$15.6M
Net margin−9968.5%———
Diluted EPS$-0.08$-0.27$-3.85$-0.47
EBITDA-$13.7M-$34.3M-$40.2M-$4.6M
Operating cash flow-$11.7M-$10.2M-$3.0M-$5.0M
Free cash flow-$26.1M-$10.2M-$3.0M-$5.0M
Diluted shares182.0M174.6M110.0M33.4M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30
Cash & equivalents$5.6M$6.9M$20.3M$11.0M
Short-term investments$14.7M$23.8M$9.7M$0.00
Total debt$0.00$0.00$38.0M$0.00
Total assets$159.6M$173.3M$187.5M$130.5M
Total liabilities$12.4M$14.0M$54.2M$137.3M
Shareholders' equity$147.1M$159.2M$133.2M-$6.9M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology